Imvaria
Clinical AI Starting in Lung Disease
- Headquarters
- Berkeley, California
- Business Model
- B2B
- Website
- imvaria.com
- Last Round
- SeedJan 2026
- Rounds
- 1
Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.
About
IMVARIA is a clinical AI company that generates novel physiologic signatures from clinical testing and imaging data, starting in lung disease.
Summary
Imvaria is an Artificial Intelligence company based in Berkeley, United States. Its most recent funding was a Seed round in Jan 2026. Investors include InHealth Ventures and Labcorp Venture Fund.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2026
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/imvaria"><img src="https://indexed.vc/api/badge/company/imvaria" alt="Imvaria on Indexed.vc" width="260" height="76" /></a>